Resources
EFFICACY
MONALEESA-7 Premenopausal HR+/HER2- mBC Brochure
Take a closer look at the results from MONALEESA-7, the only CDK4/6 inhibitor trial dedicated to premenopausal patients with HR+/HER2- mBC.
RIGHT Choice Trial Overview and Primary Data Readout
Access the latest data from the RIGHT Choice trial, studying KISQALI + AI + goserelin in 1L premenopausal patients with aggressive disease, to see how KISQALI may benefit these patients.
Data Across Age Groups Overview and Primary Data Readout
Access the data from across age groups, including elderly patients, to learn more about KISQALI for these patients.
1L, first line; AI, aromatase inhibitor; CDK, cyclin-dependent kinase; HER2-, human epidermal growth factor receptor 2-negative; HR+, hormone receptor-positive; mBC, metastatic breast cancer.
START & STAY
KISQALI Starter Guide
This guide provides assessment, dosing, and access and support information to help you get your patients started on their treatment with KISQALI.
ASSESSMENTS & DOSING
KISQALI Treatment Guide
A comprehensive guide to treatment with KISQALI + AI that includes dedicated sections to support you in treating your patients with early (stage II or III at high risk of recurrence) or metastatic HR+/HER2- breast cancer.
KISQALI Assessments Checklist
Plan ahead with this checklist to help your patients start and stay on therapy with KISQALI.
Adverse Reaction Management with KISQALI
A guide to addressing adverse reactions in patients on therapy and how KISQALI has straightforward dosing adjustments that allow patients to get the most out of their treatment.
QT Prolongation Facts & Perceptions
Learn the real facts and perceptions regarding QT prolongation with KISQALI to ensure patients receive the best possible care during treatment.
KISQALI EHR TOOLS
KISQALI EHR Guide: Oracle Cerner
A step-by-step guide to developing, configuring, and modifying Oracle Cerner EHR components relevant to treatment with KISQALI. Lab/ECG assessment and dosing information are also included for reference.
KISQALI EHR Guide: iKnowMed
A step-by-step guide to developing, configuring, and modifying iKnowMed EHR components relevant to treatment with KISQALI. Lab/ECG assessment and dosing information are also included for reference.
KISQALI EHR Guide: OncoEMR
A step-by-step guide to developing, configuring, and modifying OncoEMR EHR components relevant to treatment with KISQALI. Lab/ECG assessment and dosing information are also included for reference.
KISQALI EHR Guide: Epic
A step-by-step guide to developing, configuring, and modifying Epic EHR components relevant to treatment with KISQALI. Lab/ECG assessment and dosing information are also included for reference.
ECG, electrocardiogram; EHR, electronic health record.
PATIENT RESOURCES
Patient Brochure (English)
Help your patients find answers to many of their questions about HR+/HER2- metastatic breast cancer and treatment with KISQALI.
Folleto para pacientes (Español)
Encuentre respuestas a muchas de las preguntas de sus pacientes sobre KISQALI y el cáncer de mama metastásico HR+, HER2-.
Day-to-Day Patient Resources
Assist your patients in learning about independent support organizations that can offer services to complement treatment plans and care, such as transportation, lodging, healthy meals, home cleaning, and more.
Metastatic Breast Cancer Guide
This comprehensive guide includes information, tips, and support resources to help your patients navigate an mBC diagnosis.
Appointment Guide
This guide includes tips and conversation starters to help your patients feel empowered when discussing important treatment-related information with their care team.
ACCESS, CODING, & REIMBURSEMENT
KISQALI Access Support Guide
A guide to support patients during the insurance coverage process for KISQALI.
ICD-10-CM Flashcard
Information on potential codes for KISQALI.
Formulary Change Flashcard
Information on how to help patients stay on KISQALI during insurance changes.
KISQALI Financial Assistance Slim Jim
Information about financial support for KISQALI.